---
schema_version: "secwatch.filing_event.v1"
accession: "0001799191-23-000048"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2023-09-18T23:59:59+00:00"
generated_at: "2026-06-10T15:04:52.231130+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oncology Institute regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq notice on Sept 15, 2023 confirming compliance with Listing Rule 550(a)(2).
- Common stock closing bid price was $1.00 or more for 11 consecutive business days through Sept 14.
- Company had been non-compliant since April 25, 2023; original deadline was Oct 23, 2023.

## SEC filing metadata
- accession: 0001799191-23-000048
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2023-09-18T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000048/0001799191-23-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000048/toi-20230915.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001799191-23-000048
- JSON: https://secwatch.observer/filing/0001799191-23-000048.json
- Plain text: https://secwatch.observer/filing/0001799191-23-000048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.